Drugs that target pathogenesis of psoriasis

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1382, 2003-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of IL-23 in the pathogenesis of psoriasis: a novel potential therapeutic target?

By Chiricozzi Andrea Saraceno Rosita Chimenti Maria Sole Guttman-Yassky Emma Krueger James G

Expert Opinion on Therapeutic Targets, Vol. 18, Iss. 5, 2014-05 ,pp. : 513-525

Informa Healthcare

Access to resources Recommend Favorite

Psoriasis, from Pathogenesis to Therapeutic Strategies: IL-21 as a Novel Potential Therapeutic Target

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 10, 2012-08 ,pp. : 1861-1867

Bentham Science Publishers

Access to resources Recommend Favorite

Update on biotech drugs for psoriasis

Inpharma, Vol. 1, Iss. 1297, 2001-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Emerging drugs in psoriasis

By Gniadecki R. Calverley M.J.

Expert Opinion on Emerging Drugs, Vol. 4, Iss. 1, 1999-01 ,pp. : 309-332

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs in psoriasis

By Calverley Martin J Gniadecki Robert

Expert Opinion on Emerging Drugs, Vol. 7, Iss. 1, 2002-05 ,pp. : 69-90

Informa Healthcare

Access to resources Recommend Favorite